Correction to: JAK Inhibitors for Atopic Dermatitis: An Update

被引：0
|
作者：
Helen He
Emma Guttman-Yassky
机构：
[1] Icahn School of Medicine at Mount Sinai,Department of Dermatology and the Immunology Institute
[2] The Rockefeller University,Laboratory for Investigative Dermatology
来源：
American Journal of Clinical Dermatology | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Page 7, Table 1, ASN002 row. The cell entry in column 4, “Manufacturer”, which previously read:
引用
收藏
页码：193 / 193
相关论文
共 50 条
  • [21] Atopic dermatitis: An update
    Beltrani, VS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (03) : S85 - S86
  • [22] Atopic dermatitis update
    Sturgill, S
    Bernard, LA
    CURRENT OPINION IN PEDIATRICS, 2004, 16 (04) : 396 - 401
  • [23] JAK Inhibitors in Atopic Dermatitis Associated With Risk of Viral Infections: A Critical Appraisal
    Pathania, Y. S.
    ACTAS DERMO-SIFILIOGRAFICAS, 2023, 114 (03): : 277 - 278
  • [24] Should atopic dermatitis patients starting JAK inhibitors take prophylactic acyclovir?
    Shah, Milaan A.
    Beuerlein, Katherine G.
    Jorizzo, Joseph L.
    Feldman, Steven R.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (07) : 669 - 672
  • [25] Not 'Just Another Kinase': The therapeutic potential of JAK inhibitors in the treatment of atopic dermatitis
    Le, M.
    Rosa, M. Berman
    Ghazawi, F.
    Litvinov, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S122 - S122
  • [26] Response to biological drugs and JAK inhibitors following cyclosporine in patients with atopic dermatitis
    Urena-Paniego, Clara
    Sanabria-de-la-Torre, Raquel
    Ramirez-Munoz, Arena
    Soto-Moreno, Alberto
    Arias-Santiago, Salvador
    Montero-Vilchez, Trinidad
    EUROPEAN JOURNAL OF DERMATOLOGY, 2024, 34 (04) : 409 - 415
  • [27] The efficacy of Janus Kinase (JAK) inhibitors in treating atopic dermatitis: a systematic review
    Arora, C. J.
    Shumack, S.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 23 - 24
  • [28] JAK1 inhibitors for the treatment of atopic dermatitis: a focus on pharmacokinetic considerations
    Kopelman, Hannah
    Kontzias, Christina
    Alihosseni, Christopher
    Feldman, Steven R.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (08) : 537 - 542
  • [29] JAK inhibitors for atopic dermatitis: A network meta-analysis of adverse events
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 324 - 325
  • [30] Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors
    Kirchhof, Mark G.
    Prajapati, Vimal H.
    Gooderham, Melinda
    Hong, Chih-ho
    Lynde, Charles W.
    Maari, Catherine
    Turchin, Irina
    Papp, Kim A.
    DERMATOLOGY AND THERAPY, 2024, 14 (09) : 2653 - 2668
12345